At a glance
- Originator Eukarion
- Class Anti-ischaemics; Neuroprotectants; Organometallic compounds; Salicylates; Small molecules
- Mechanism of Action Antioxidants; Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy; Stroke
Most Recent Events
- 16 Dec 2003 No development reported - Preclinical for Stroke in USA (unspecified route)
- 05 Jan 1999 Preclinical development for Stroke in USA (Unknown route)